Tron T, Lemesle-Meunier D
Unité de Métabolisme Energétique, L.C.B, B.P. n. 3, Marseille, France.
Curr Genet. 1990 Dec;18(5):413-9. doi: 10.1007/BF00309910.
Two cytochrome b respiratory-deficient mutants were sequenced and their DNA base change identified, leading to the replacement of glycine (G137 by valine or glutamic acid. No variation in their cytochrome b content with regard to cytochrome oxidase and cytochrome (c + c1) was found to have occurred. Their cellular respiratory activity with various substrates was partly conserved and was totally inhibited by antimycin A. Their ubiquinol (QH2)-cytochrome c reductase/mole cytochrome b activity decreased by about 50%. Paradoxically their growth on respiratory substrate was abolished. Both mutants retained a high-affinity binding site for antimycin A, and exhibited a myxothiazol-resistance at the mitochondrial level. It seems likely that the mutated position (137), which belongs to the ubiquinol oxidizing domain of the bc1 complex, interferes, directly or indirectly, with the respiratory growth capacity of the cell.
对两个细胞色素b呼吸缺陷型突变体进行了测序,并确定了它们的DNA碱基变化,导致甘氨酸被缬氨酸或谷氨酸取代(G137)。未发现它们的细胞色素b含量在细胞色素氧化酶和细胞色素(c + c1)方面发生变化。它们利用各种底物的细胞呼吸活性部分得以保留,并被抗霉素A完全抑制。它们的泛醇(QH2)-细胞色素c还原酶/摩尔细胞色素b活性降低了约50%。矛盾的是,它们在呼吸底物上的生长被消除了。两个突变体都保留了抗霉素A的高亲和力结合位点,并在线粒体水平上表现出抗霉素噻唑抗性。似乎属于bc1复合体泛醇氧化结构域的突变位置(137)直接或间接地干扰了细胞的呼吸生长能力。